Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 5/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.59 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.59 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.56 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.51 |
| ▸ | TDO2 | P48775 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2783746 | 1.00 | CYP1A1 (0.59) | CYP1A1CYP1A2CYP1B1CYP11B1CYP11B2 | |
| SCHEMBL3170614 | 0.81 | CYP11B1 (0.59) | CYP1A1CYP1A2CYP1B1CYP11B1CYP11B2 | |
| SCHEMBL24105498 | 0.79 | CYP11B1 (0.46) | CYP1A1CYP1A2CYP1B1CYP11B1CYP11B2 | |
| SCHEMBL24105528 | 0.79 | CYP11B1 (0.46) | CYP1A1CYP1A2CYP1B1CYP11B1CYP11B2 | |
| SCHEMBL28878216 | 0.77 | CYP11B1 (0.50) | CYP1A1CYP1A2CYP1B1CYP11B1CYP11B2 | |
| SCHEMBL29691623 | 0.75 | CYP11B1 (0.86) | CYP11B1CYP11B2CYP2D6MEN1NPC1 | |
| SCHEMBL29691639 | 0.75 | CYP11B1 (0.86) | CYP11B1CYP11B2CYP2D6MEN1NPC1 | |
| SCHEMBL554004 | 0.75 | MAOB (0.45) | CYP1B1PTGS1PTGS2 | |
| SCHEMBL29961731 | 0.75 | MAOB (0.45) | CYP1B1PTGS1PTGS2 | |
| SCHEMBL554003 | 0.75 | MAOB (0.45) | CYP1B1PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102080131-B | Hairpin type DNA modified gold colloid nano particles and synthesizing method thereof | UNIV ZHENGZHOU | 2012-11-21 | — | — | CN | disclosed |
| CN-102080131-A | Hairpin type DNA modified gold colloid nano particles and synthesizing method thereof | UNIV ZHENGZHOU | 2011-06-01 | — | — | CN | disclosed |
| US-20100236942-A1 | METHOD FOR ELECTROCHEMICAL DETECTION OF NUCLEIC ACID SEQUENCES | UNIVERSIDAD AUTONOMA DE MADRID (ES) | 2010-09-23 | — | — | US | disclosed |
| US-20100236942-A1 | METHOD FOR ELECTROCHEMICAL DETECTION OF NUCLEIC ACID SEQUENCES | UNIVERSIDAD AUTONOMA DE MADRID (ES) | 2010-09-23 | — | — | US | disclosed |
| EP-2168949-A1 | METHOD FOR ELECTROCHEMICAL DETECTION OF SEQUENCES OF NUCLEIC ACIDS | Universidad Autónoma de Madrid (ES) | 2010-03-31 | — | — | EP | disclosed |
| EP-2168949-A1 | METHOD FOR ELECTROCHEMICAL DETECTION OF SEQUENCES OF NUCLEIC ACIDS | Universidad Autónoma de Madrid (ES) | 2010-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100236942-A1 | METHOD FOR ELECTROCHEMICAL DETECTION OF NUCLEIC ACID SEQUENCES | POLRMT, POLM, POLL | CYP1A1 1410/4885CYP1A2 2204/4885CYP1B1 1360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.